GLP-1 meds may help — or harm — those with bipolar disorder. Read firsthand accounts of mood changes, weight loss, and side ...

A recent study reveals a surge in the use of GLP-1 medications, such as Ozempic and Wegovy, among younger age groups.

A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

While Americans understand the benefits of GLP-1 agonist medications, 83% of Americans are unwilling to pay more than $100 in ...

David Kessler, former FDA commissioner, discusses the use of GLP-1 weight loss drugs, ‘toxic fat’ and the importance of one’s relationship with food on ‘Fox & Friends Weekend’.

New guidelines from the Society for Perioperative Assessment and Quality Improvement advise patients using GLP-1 medications for weight loss to fast for a longer period of time preoperatively, ...

Early-stage study results suggest that a single shot of the company’s therapy, which works differently than GLP-1 medicines, ...

Shares of weight-loss drug developer Metsera gained as much as 25% on Monday after the company's experimental drug helped patients lose weight in a small, early-stage trial, showing potential for a ...

In what Guggenheim Partners called one of Metsera’s “critical program milestones” this year, its ultra-long-acting amylin ...

Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this ...

Metsera has linked its amylin analog to 8.4% placebo-adjusted weight loss at Day 36, advancing its push to develop an ...

Obesity medicine physician Dr. Alexandra Sowa reacts to a study indicating GLP-1 weight loss medications potentially increase the risk of macular degeneration in some users.